Actinogen Medical

(ASX) ACW

Current PriceA$0.04

Market CapA$159.83M

Since IPO (2007)-93%

5 Year-63%

1 Year+72%

1 Month+26%

Actinogen Medical Financials at a Glance

Market Cap

A$159.83M

Revenue (TTM)

A$14.51M

Net Income (TTM)

-A$27.57M

EPS (TTM)

-A$0.01

P/E Ratio

-7.68

Dividend

A$0.00

Beta (Volatility)

-0.04 (Low)

Dividend

A$0.00

Beta (Volatility)

-0.04 (Low)

Price

A$0.04

Volume

772,222

Open

A$0.04

Price

A$0.04

Volume

772,222

Open

A$0.04

Previous Close

A$0.04

Daily Range

A$0.04 - A$0.04

52-Week Range

A$0.02 - A$0.07

Estimated Earnings Date

Aug 31, 2026

Dividend

A$0.00

Beta (Volatility)

-0.04 (Low)

Price

A$0.04

Volume

772,222

Open

A$0.04

Previous Close

A$0.04

Daily Range

A$0.04 - A$0.04

52-Week Range

A$0.02 - A$0.07

Estimated Earnings Date

Aug 31, 2026

ACW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Actinogen Medical

Industry

Biotechnology

Sector

Health Care

CEO

Steven G. Gourlay, MD, PhD

Website

www.actinogen.com.au

Headquarters

Sydney, NSW 2000, AU

ACW Financials

Key Financial Metrics (TTM)

Gross Margin

96.16%

Operating Margin

-365.31%

Net Income Margin

-326.26%

Return on Equity

-134.14%

Return on Capital

-69.13%

Return on Assets

-168.94%

Earnings Yield

-13.02%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$159.83M

Shares Outstanding

3.72B

Volume

772.22K

Avg. Volume

3.53M

Financials (TTM)

Gross Profit

A$14.10M

Operating Income

-A$29.61M

EBITDA

-A$29.52M

Operating Cash Flow

-A$25.13M

Capital Expenditure

-A$47.40K

Free Cash Flow

-A$25.18M

Cash & ST Invst.

A$6.53M

Total Debt

A$366.31K

Actinogen Medical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

A$0.00

-100.0%

Gross Profit

-A$210.68K

-130.2%

Gross Margin

0.00%

N/A

Market Cap

A$159.83M

N/A

Market Cap/Employee

A$26.64M

N/A

Employees

N/A

Net Income

-A$11.35M

+1.8%

EBITDA

-A$13.07M

-6.8%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

A$6.53M

-43.1%

Total Debt

A$366.31K

+720.8%

Accounts Receivable

A$2.18M

+544.6%

Inventory

A$0.00

N/A

Long Term Debt

A$284.84K

N/A

Short Term Debt

A$81.47K

-8.7%

Return on Assets

-1.69%

N/A

Return on Invested Capital

-2.36%

N/A

Free Cash Flow

-A$7.12M

-9.7%

Operating Cash Flow

-A$7.12M

-9.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SDI.AXSDI Limited

SDI.AXSDI LimitedA$1.40+0.14%

ATH.AXAlterity Therapeutics Limited

ATH.AXAlterity Therapeutics LimitedA$0.58-4.17%

ILA.AXIsland Pharmaceuticals Limited

ILA.AXIsland Pharmaceuticals LimitedA$0.44-6.38%

RCE.AXRecce Pharmaceuticals Ltd

RCE.AXRecce Pharmaceuticals LtdA$0.37-5.19%

ALA.AXArovella Therapeutics Limited

ALA.AXArovella Therapeutics LimitedA$0.07+1.54%

BIO.AXBiome Australia Limited

BIO.AXBiome Australia LimitedA$0.26+2.97%

IMU.AXImugene Limited

IMU.AXImugene LimitedA$0.10-1.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$15.62-0.00%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$74.35-0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$38.99+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.41+0.00%

TET1 Energy Inc.

TET1 Energy Inc.$6.65-0.03%

MARAMara Holdings

MARAMara Holdings$12.30+0.01%

CLSKCleanSpark

CLSKCleanSpark$14.26+0.06%

Questions About ACW

What is the current price of Actinogen Medical?

Actinogen Medical is trading at A$0.04 per share.

What is the 52-week range for Actinogen Medical?

Over the past 52 weeks, Actinogen Medical has traded between A$0.02 and A$0.07.

How much debt does Actinogen Medical have?

As of the most recent reporting period, Actinogen Medical reported total debt of A$3.26M.

How much cash does Actinogen Medical have on hand?

Actinogen Medical reported A$16.50M in cash and cash equivalents in its most recent financial results.

What is Actinogen Medical’s dividend yield?

Actinogen Medical does not currently have a dividend yield.

Actinogen Medical

Actinogen Medical Financials at a Glance

ACW News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Actinogen Medical

ACW Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Actinogen Medical Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ACW

What is the current price of Actinogen Medical?

What is the 52-week range for Actinogen Medical?

How much debt does Actinogen Medical have?

How much cash does Actinogen Medical have on hand?

What is Actinogen Medical’s dividend yield?

Premium Investing Services